Spain (ES)

Protein-based (bio)materials: a way toward high-performance graphene enzymatic biosensors (2022) Silvestri A, Wang F, Feng X, Cortajarena AL, Prato M Journal article Reference database of total retinal vessel surface area derived from volume-rendered optical coherence tomography angiography (2022) Maloca PM, Feu-Basilio S, Schottenhamml J, Valmaggia P, Scholl HP, Rosinés-Fonoll J, Marin-Martinez S, et al. Journal article Association between FIASMA psychotropic medications and reduced risk of intubation or death in individuals with psychiatric disorders hospitalized for severe COVID-19: an observational multicenter study (2022) Hoertel N, Sánchez-Rico M, Gulbins E, Kornhuber J, Carpinteiro A, Abellán M, de la Muela P, et al. Journal article COVID-19 Vaccinations: Summary Guidance for Cancer Patients in 28 Languages: Breaking Barriers to Cancer Patient Information (2022) Mauri D, Kamposioras K, Tsali L, Dambrosio M, De Bari B, Hindi N, Salembier C, et al. Journal article Assessing dependence and governance as value chain risks: Natural Gas versus Concentrated Solar power plants in Mexico (2022) Gamarra AR, Lechón Y, Escribano G, Lilliestam J, Lázaro L, Caldés N Journal article Fault-Tolerant Parity Readout on a Shuttling-Based Trapped-Ion Quantum Computer (2022) Hilder J, Pijn D, Onishchenko O, Stahl A, Orth M, Lekitsch B, Rodriguez-Blanco A, et al. Journal article Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA) (2022) Hayden PJ, Roddie C, Bader P, Basak GW, Bonig H, Bonini C, Chabannon C, et al. Journal article Clinical outcomes of everolimus-eluting bioresorbable scaffolds or everolimus-eluting stents in patients with acute myocardial infarction: two-year results of the randomised ISAR-Absorb MI trial (2022) Wiebe J, Byrne RA, Alfonso F, Maeng M, Bradaric C, Kretov E, Cuesta J, et al. Journal article Impact of a reduced dosing interval of lanreotide autogel (LAN) on tumor growth rate (TGR) in patients with progressive neuroendocrine tumors (NETs) in the prospective, single-arm, phase 2 CLARINET FORTE trial (2022) Dromain C, Cwikla JB, Lombard-Bohas C, Borbath , Shah T, Pape UF, Capdevila J, et al. Conference contribution Comparative Efficacy and Safety of Tirbanibulin for Actinic Keratosis of the Face and Scalp in Europe: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials (2022) Heppt M, Dykukha I, Graziadio S, Salido-Vallejo R, Chapman-Rounds M, Edwards M Journal article, Review article